Company Summary
Incorporated in 2008, Vascular Dynamics, Inc.'s first device is the MobiusHD™* implant. The MobiusHD™ represents an entirely new form of treatment for patients suffering from drug-resistant hypertension.
Introduction:
Introduction:
Vascular Dynamics, Inc. (VDI) is a privately-held company founded in 2008 by Rainbow Medical Ltd. (Rainbow). Rainbow is a healthcare accelerator developing the technologies invented by Israeli inventor, Yossi Gross. In November 2011, VDI's development and commercialization efforts were moved to Mountain View, CA.
VDI has developed a passive, catheter-delivered implant for the treatment of high blood pressure, also referred to as hypertension. Collectively, the VDI team has over 75 years of experience developing and commercializing medical devices.
Hypertension affects over 74 million people in the United States and is estimated to cause 1 in every 8 deaths worldwide.1 It is a major risk factor for cardiovascular disease, morbidity, and mortality. It is a costly disease, with treatment of hypertensive patients in the U.S. costing an estimated $60 billion a year. Twenty-five percent of hypertensive people are unable to adequately regulate their hypertension with medications and lifestyle modifications.2,3
VDI has developed a passive, catheter-delivered implant for the treatment of high blood pressure, also referred to as hypertension. Collectively, the VDI team has over 75 years of experience developing and commercializing medical devices.
Hypertension affects over 74 million people in the United States and is estimated to cause 1 in every 8 deaths worldwide.1 It is a major risk factor for cardiovascular disease, morbidity, and mortality. It is a costly disease, with treatment of hypertensive patients in the U.S. costing an estimated $60 billion a year. Twenty-five percent of hypertensive people are unable to adequately regulate their hypertension with medications and lifestyle modifications.2,3
1 AHA Statistical Update - Heart Disease and Stroke Statistics--2009 Update. Circulation, 2009; 119:e21-e181.
2 Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet, 2002; 360:1903-1913.
3 Chobanian, A.V. et. al., The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA, 2003; 289(19):2560-2571.
Vascular Dynamics, Inc. • 2134 Old Middlefield Way • Suite J • Mountain View, CA • 94043
* CAUTION: Investigational device. Limited by Federal (United States) law to investigational use.
* CAUTION: Investigational device. Limited by Federal (United States) law to investigational use.
